HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mónica Ambriz-Tututi Selected Research

ICI 204448

11/2007Subcutaneous, intrathecal and periaqueductal grey administration of asimadoline and ICI-204448 reduces tactile allodynia in the rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mónica Ambriz-Tututi Research Topics

Disease

11Hyperalgesia
01/2018 - 07/2006
4Pain (Aches)
12/2016 - 04/2009
2Parkinson Disease (Parkinson's Disease)
01/2018 - 01/2008
1Low Back Pain (Lumbago)
12/2016
1Chronic Pain
10/2013
1Hyperphagia (Overeating)
04/2010
1Polyuria
04/2010
1Polydipsia
04/2010
1Neuralgia (Stump Neuralgia)
04/2009
1Inflammation (Inflammations)
01/2008
1Epilepsy (Aura)
01/2008
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2008
1Alzheimer Disease (Alzheimer's Disease)
01/2008
1Cancer Pain
01/2008
1Huntington Disease (Huntington's Disease)
01/2008
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2008
1Hyperglycemia
12/2007

Drug/Important Bio-Agent (IBA)

6Formaldehyde (Formol)FDA Link
01/2018 - 12/2007
3Opioid Receptors (Opioid Receptor)IBA
10/2009 - 12/2007
3MelatoninIBA
04/2009 - 12/2007
2Analgesics (Analgesic Drugs)IBA
12/2016 - 10/2011
2Streptozocin (Streptozotocin)FDA Link
04/2010 - 12/2007
2Messenger RNA (mRNA)IBA
04/2010 - 11/2007
2ResveratrolIBA
01/2008 - 07/2006
1Oxidopamine (6 Hydroxydopamine)IBA
01/2018
1Glutamate Receptors (Glutamate Receptor)IBA
10/2013
1N-Methylaspartate (NMDA)IBA
05/2012
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
05/2012
1Adrenergic Agents (Adrenergic Drugs)IBA
10/2011
1Opioid Peptides (Opioid Peptide)IBA
10/2011
1AminesIBA
10/2011
1lorglumideIBA
05/2011
1YM 022IBA
05/2011
1Cholecystokinin (Pancreozymin)IBA
05/2011
1Dynorphins (Dynorphin)IBA
05/2011
1Lidocaine (Xylocaine)FDA LinkGeneric
05/2011
1Cholecystokinin Receptors (Cholecystokinin Receptor)IBA
05/2011
1Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2010
1Cyclic GMPIBA
04/2010
1Nitroglycerin (Dynamite)FDA LinkGeneric
04/2010
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
04/2010
1Sildenafil Citrate (Viagra)FDA Link
04/2010
1Nitric Oxide DonorsIBA
04/2010
1EnkephalinsIBA
10/2009
1Morphine (MS Contin)FDA LinkGeneric
10/2009
1Leucine-2-Alanine Enkephalin (Enkephalin, Leucine 2 Alanine)IBA
10/2009
1(trans)-Isomer 3,4- Dichloro- N- methyl- N- (2- (1- pyrrolidinyl)- cyclohexyl)- benzeneacetamideIBA
10/2009
1NociceptinIBA
10/2009
1Melatonin Receptors (Melatonin Receptor)IBA
04/2009
1Hormones (Hormone)IBA
04/2009
1Free RadicalsIBA
04/2009
1ICI 204448IBA
11/2007
1asimadolineIBA
11/2007
1Naloxone (Narcan)FDA LinkGeneric
11/2007
1kappa Opioid Receptors (kappa Opioid Receptor)IBA
11/2007
13- (5'- hydroxymethyl- 2'- furyl)- 1- benzylindazoleIBA
07/2006
1Soluble Guanylyl CyclaseIBA
07/2006

Therapy/Procedure

3Ligation
12/2007 - 07/2006
2Oral Administration
12/2007 - 12/2007
1Physical Therapy Modalities (Physical Therapy Technique)
12/2016
1Transcranial Magnetic Stimulation
12/2016
1Drug Therapy (Chemotherapy)
04/2010